Lb Pharmaceuticals (LBRX) Pension (2024 - 2026)

Lb Pharmaceuticals' (LBRX) quarterly Pension came in at $262000.0 in Q1 2026, down 49.13% quarter-over-quarter from $515000.0 in Q4 2025.

Lb Pharmaceuticals (LBRX) Pension (2024 - 2026) Analysis & Trends

Lb Pharmaceuticals' Pension history runs 3 years deep, the most recent figure standing at $262000.0 for Q1 2026.

  • On a quarterly basis, Pension changed N/A year-over-year to $262000.0 in Q1 2026; TTM through Mar 2026 was $262000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $515000.0, down 35.62% from the prior year.
  • Pension slipped to $262000.0 in Q1 2026 per LBRX's latest filing, from $515000.0 in the prior quarter.
  • Across five years, Pension topped out at $868000.0 in Q3 2025 and bottomed at $262000.0 in Q1 2026.
  • The 3-year median for Pension is $657500.0 (2024), against an average of $611250.0.
  • Biggest YoY gain for Pension was 35.62% in 2025; the steepest drop was 35.62% in 2025.
  • Year by year, Pension stood at $800000.0 in 2024, then tumbled by 35.62% to $515000.0 in 2025, then plunged by 49.13% to $262000.0 in 2026.
  • Per Business Quant, the three latest LBRX Pension figures stand at $262000.0 (Q1 2026), $515000.0 (Q4 2025), and $868000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Lb Pharmaceuticals 977.73 Mn 977.73 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 262,000.00
Dec 31, 2025 515,000.00
Sep 30, 2025 868,000.00
Dec 31, 2024 800,000.00